In many ways, the COVID-19 pandemic accelerated innovation in biomedical research, while also revealing the industry’s shortcomings.
Many sites, sponsors, and CROs implemented new digital tools on the fly, sometimes without solidifying longer-term data and technology strategies. But emerging approaches in clinical trial design and execution offer solutions, potentially increasing the probability of a therapeutics’ approval while improving participant experience.
Explore this research-backed MedTech Dive studioID Industry Outlook report to learn:
- Innovative clinical trial designs and protocols
- Regulations impacting technology adoption and use
- Strategies for building more efficient, accessible, and inclusive trials
- Technology attributes that support successful outcomes